Page last updated: 2024-10-21

mercaptoethanol and Carcinoma, Small Cell

mercaptoethanol has been researched along with Carcinoma, Small Cell in 4 studies

Mercaptoethanol: A water-soluble thiol derived from hydrogen sulfide and ethanol. It is used as a reducing agent for disulfide bonds and to protect sulfhydryl groups from oxidation.

Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banham, S1
Soukop, M1
Burnett, A1
Stevenson, R1
Cunningham, D1
Tansey, P1
Ahmedzai, S1
Stack, B1
Dorward, A1
Lucie, N1
Holoye, PY1
Glisson, BS1
Lee, JS1
Dhingra, HM1
Murphy, WK1
Umsawasdi, T1
Levy, JK1
Jeffries, D1
Raber, MN1
Hong, WK1
Cantwell, BM2
Harris, AL2
Bozzino, JM1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase Ⅱ Randomized Clinical Trial Comparing Vinorelbine-ifosfamide With Gefitinib as Third-line Treatment in Advanced EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients[NCT01749072]Phase 2120 participants (Anticipated)Interventional2012-12-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for mercaptoethanol and Carcinoma, Small Cell

ArticleYear
Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Evaluation; Humans; Ifos

1986

Other Studies

3 other studies available for mercaptoethanol and Carcinoma, Small Cell

ArticleYear
Treatment of small cell carcinoma of lung with late dosage intensification programmes containing cyclophosphamide and mesna.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Adult; Aged; Carcinoma, Small Cell; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lun

1983
Ifosfamide with mesna uroprotection in the management of lung cancer.
    American journal of clinical oncology, 1990, Volume: 13, Issue:2

    Topics: Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans

1990
Ifosfamide/mesa and encephalopathy.
    Lancet (London, England), 1985, Mar-30, Volume: 1, Issue:8431

    Topics: Brain Diseases; Carcinoma, Small Cell; Cyclophosphamide; Female; Humans; Ifosfamide; Lung Neoplasms;

1985